You just read:

Ardelyx Showcases New Data from T3MPO-3 Long-Term Safety Trial of Tenapanor for IBS-C in Presidential Poster at ACG 2018 Annual Meeting

News provided by

Ardelyx

Oct 08, 2018, 08:01 ET